DAFTAR PUSTAKA

1. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric

SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.
Nature Medicine. 2020;26(4):502–5.
2. World Health Organization. WHO coronavirus (COVID-19) dashboard | WHO
coronavirus (COVID-19) dashboard with vaccination data. Oxford: WHO; 2023.
3. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19
virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ
Res. 2020;188:1-18
4. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2
receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci [Internet].
2020;12(1):1–5.
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–
506.
6. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of
Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
7. Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a
postinfectious entity?. Clin Microbiol Infect. 2020;26(11):1448-49.
8. Scarpetta S, Pearson M, Colombo F, Lopert R, Dedet G, Wenzel M. Access to
COVID-19 vaccines: Global approaches in a global crisis. OECD Policy Responses to
Coronavirus. 2021;(March):1–30.
9. Ophinni Y, Hasibuan AS, Widhani A, Maria S. COVID-19 vaccines: current status and
implication for use in Indonesia. Acta Med Indonesia. 2020;52(4):388–412.
10. Elias MD, Truong DT, Oster ME, Trachtenberg FL, Mu X, Jone PN, et al.
Examination of adverse reactions after COVID-19 vaccination among patients with a
history of multisystem inflammatory syndrome in children. JAMA Netw open.
2023;6(1):1-14.
11. Wichova H, Miller ME, Derebery MJ. Otologic manifestations after COVID-19
vaccination: the house ear clinic experience. Otol Neurotol. 2021;42(9):e1213–8.
12. Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik
Indonesia nomor 12 tahun 2017 tentang penyelenggaraan imunisasi. Jakarta:
Kementrian Kesehatan Republik Indonseia; 2017.
13. Komite Nasional PP-KIPI. Laporan KIPI COVID-19 di Indonesia. Jakarta:Kementrian
Kesehatan Republik Indonesia; 2022.
14. Lachowska M, Pastuszka A, Sokołowski J, Szczudlik P, Niemczyk K. Cortical
deafness due to ischaemic strokes in both temporal lobes. J Audiol Otol.
2021;25(3):163–70.
15. Liu Y chun C, Ibekwe T, Kelso JM, Klein NP, Shehu N, Steuerwald W, et al.
Sensorineural hearing loss (SNHL) as an adverse event following immunization
(AEFI): case definition & guidelines for data collection, analysis, and presentation of
 immunization safety data. Vaccine. 2020;38(30):4717–31.
16. Li S, Cheng C, Lu L, Ma X, Zhang X, Li A. Hearing loss in neurological disorders.
Front Cell Dev Biol 2021;9:1–16.
17. Bonetti L, Šimunjak B, Franić J. Validation of self-reported hearing loss among adult
Croatians: the performance of the Hearing Self-Assessment Questionnaire against
audiometric evaluation. Int J Audiol. 2018;57(1):1–9.
18. Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et
al. Coronavirus disease 2019: Tinjauan literatur terkini. Jurnal Penyakit Dalam
Indonesia. 2020;7(1):45-67.
19. Suni NSP. Tingginya kasus aktif dan angka kematian akibat Covid-19 di Indonesia. J
Pus Peneliti Badan Keahlian DPR RI. 2021;13(3):13–8.
20. Lotfi MR, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and
potential therapeutic opportunities. Clin Chim Acta. 2020;508:254–66.
21. Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, genome organization,
replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). 2020;2:23–31.
22. Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: structure,
biology, and structure-based therapeutics development. Front Cell Infect Microbiol.
2020;10(November):1–17.
23. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology,
transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): A
Review. JAMA. 2020;324(8):782–93.
24. Rengganis I. Vaksinasi pada lansia. Jurnal Penyakit Dalam Indonesia. 2017;4(4):167.
25. Baxter R, Lewis N, Bohrer P, Harrington T, Aukes L, Klein NP. Sudden-Onset
sensorineural hearing loss after immunization: A Case-Centered Analysis. Otolaryngol
Head Neck Surg. 2016 Jul;155(1):81-6.
26. Mahanty S, Prigent A, Garraud O. Immunogenicity of infectious pathogens and
vaccine antigens. BMC Immunol. 2015;16(1):31–6.
27. World Health Organization (WHO). Background document on the inactivated vaccine
Sinovac-CoronaVac against COVID-19. Geneva: WHO; 2021.
28. Logunov DY, Dolzhikova I V., Shcheblyakov D V., Tukhvatulin AI, Zubkova O V.,
Dzharullaeva AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based
heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised
controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–81.
29. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines-a new era in
vaccinology. Nat Rev Drug Discov. 2018;17(4):261–79.
30. Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: types, thoughts, and application.
J Clin Lab Anal. 2021;35(9):1–7.
31. Ribeiro GE, da Silva DPC. Audiological implications of COVID-19: an integrative
literature review. Rev CEFAC. 2021;23(1):1–7.
32. Speiser DE, Bachmann MF. Covid-19: Mechanisms of vaccination and immunity.
 Vaccines. 2020;8(3):1–22.
33. World Health Organization. Interim statement on covid-19 vaccine booster doses.
Riyadh: Geneva; 2021;26(4):403–5.
34. Vogel L, Duong D. What’s the evidence for COVID-19 booster shots? CMAJ.
2021;193(35):E1400–1.
35. Kementerian Kesehatan RI. Vaksin Dashboard. Vaksin Dashboard. 2022. Tersedia
dari: https://vaksin.kemkes.go.id
36. Kementerian Kesehatan Republik Indonesia. Survei penerimaan vaksin COVID-19 di
Indonesia. Jakarta: Kementrian Kesehatan Republik Indonesia; 2020.
37. Ontario Public Health. Adverse events of special interest ( AESIs ) for COVID-19
vaccines surveillance types of adverse events vaccine-associated enhanced disease.
Ontario: Ontario Public Health; 2020:1–14.
38. Koesnoe S. Teknis pelaksanaan vaksin covid dan antisipasi KIPI. Jakarta:
Perhimpunan dokter spesialis Penyakit Dalam Indonesia; 2021.
39. Avcı H, Karabulut B, Eken HD, Faraşoğlu A, Çakil T, Çoruk S, et al. Otolaryngology-
specific symptoms may be highly observed in patients with a history of Covid-19
infection after inactivated coronavirus vaccination. Ear Nose Throat J. 2021;8:1-5.
40. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Petunjuk Teknis:
Surveilans kejadian ikutan dengan perhatian khusus di rumah sakit sentinel pada
pelaksanaan vaksinasi COVID-19. Jakarta: Kementerian Kesehatan RI; 2021.
41. Hadinegoro SRS. Kejadian ikutan pasca imunisasi. Jakarta: Sari Pediatri; 2016;2(1):2-
10.
42. Kementerian Kesehatan RI. Definisi operasional & ICD-10 versi tahun 2010 KIPK.
Jakarta: Kementerian Kesehatan RI; 2020.
43. GBD 2019 Hearing Loss Collaborators. Hearing Loss Prevention and Years Lived
with Disability, 1990-2019: Findings From the Global Burden of Disease Study 2019.
The Lancet 2021; 397(10278): 996-1009.
44. Chin CJ, Dorman K. Sudden sensorineural hearing loss. CMAJ. 2017;189(11):E437–8.
45. Oliver ER, Hashisaki GT. Bailey’s head & neck surgery otolaryngology. 5th edition.
New York: Lippincott Williams & Wilkins; 2013. 2589–96.
46. Glattke TJ, Robinette MS. Audiology diagnosis. New York: Thieme Medical
Publishers; 2007. 432-58.
47. Singh A, Kumar Irugu DV. Sudden sensorineural hearing loss – A contemporary
review of management issues. J Otol. 2020;15(2):67–73.
48. Stach BA, Ramachandran V. Clinical audiology: an introduction. San diego: Plural
Publishing, Inc; 2022. 233–477.
49. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing
loss: a review of diagnosis, treatment, and prognosis. Trends Amplif. 2011;15(3):91–
105.
50. Parrino D, Frosolini A, Gallo C, De Siati RD, Spinato G, de Filippis C. Tinnitus
following COVID-19 vaccination: report of three cases. Int J Audiol. 2021;0(0):1–4.
51. Tsetsos N, Poutoglidis A, Vlachtsis K, Kilmpasanis A, Gougousis S. Sudden
sensorineural hearing loss following the second dose of COVID-19 vaccine. Cureus.
2021;13(8):8–11.
52. Chen C, Fu F, Ding L, Xiao J. Hearing disorder following COVID-19 vaccination: a
pharmacovigilance analysis using the vaccine adverse event reporting system. J Clin
Pharm Ther. 2022;47(11):1789–95.
53. Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol
Neurotol. 2013;34(9):1586–9.
54. Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 vaccine
hesitancy among young adults in Saudi Arabia: a cross-sectional web-based study.
Vaccines; 2021;9(4):330-8.
55. Hoffman HJ, Dobie RA, Losonczy KG, Themann CL, Flamme GA. Declining
prevalence of hearing loss in US adults aged 20 to 69 years. JAMA Otolaryngol - Head
Neck Surg. 2017;143(3):274–85.
56. Filippatos F, Tatsi EB, Dellis C, Dessypris N, Syriopoulou V, Michos A. Association
of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA
vaccine short-term adverse reactions in healthcare workers. Hum Vaccines
Immunother. 2021;17(12):4755–60.
57. Yanir Y, Doweck I, Shibli R, Najjar-Debbiny R, Saliba W. Association between the
BNT162b2 Messenger RNA COVID-19 Vaccine and the Risk of Sudden
Sensorineural Hearing Loss. JAMA Otolaryngol - Head Neck Surg. 2022;148(4):299–
306.
58. Okhovat S, Fox R, Magill J, Narula A. Sudden onset unilateral sensorineural hearing
loss after rabies vaccination. BMJ Case Rep. 2015:1-4.
59. Tizard IR. Adverse consequences of vaccination. Amsterdam: Elsevier; 2021;115-130.
60. Ahsan W, Syed NK, Alsraeya AA, Alhazmi HA, Najmi A, Bratty M Al, et al. Post-
vaccination survey for monitoring the side effects associated with COVID-19 vaccines
among healthcare professionals of Jazan province, Saudi Arabia. Saudi Med.
2021;42(12):1341–52.
61. Skarżyńska MB, Kołodziejak A, Gos E, Sanfis MD, Skarżyński PH. Effectiveness of
various treatments for sudden sensorineural hearing loss—A Retrospective Study.
Life. 2022;12-13.